$0.0589
At close: Aug 20, 4:22 PM EDT
$0.0800
0.0235.82%
After Hours: Aug 20, 4:22 PM EDT
Comments
Loading...
Inhibitor Therapeutics Earnings Estimates, EPS & Revenue | OTC:INTI | Benzinga
Inhibitor Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
EPS
–
Quarterly Revenue
–
Annual Revenue
(as of Mar 31)
(as of Mar 31)
–
Analyze the earnings history of Inhibitor Therapeutics using advanced sorting and filters.
| Get Alert | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
No data available to display | ||||||||||||
Inhibitor Therapeutics (INTI) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
Inhibitor Therapeutics (INTI) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Inhibitor Therapeutics (OTCQB:INTI) reporting earnings?
There are no earnings for Inhibitor Therapeutics
What were the latest earnings per share (EPS) for Inhibitor Therapeutics (OTCQB:INTI)?
There are no earnings for Inhibitor Therapeutics
What were Inhibitor Therapeutics’s (OTCQB:INTI) revenues?
There are no earnings for Inhibitor Therapeutics
Browse earnings estimates, EPS, and revenue on all stocks.
